News Litmus and NIH study use of wearables in cancer R&D Health data firm Litmus Health has been awarded a contract with the National Cancer Institute of the US National Institutes of Health, to use “real-world” digital data to improve drug devel
News LEO Pharma teams up with Wearifi for dermatology research we... LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development.
News Wearables still lack evidence of patient outcomes Out of 4,000 studies, review found only 16 were high quality.
Partner Content Partner Content The rise of wearable technology for clinical trials: insight... The rise of wearable technology for clinical trials
Partner Content Partner Content PLIVA explores impact of EU Guidelines on evaluation of modi... PLIVA explores EU Guidelines for modified release drugs
Partner Content Partner Content The 10th Annual Social Media in Pharma – Exclusive Speaker I... Social Media in Pharma
News Trump sets course for 100%, then 200%, tariffs on generics Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.